Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients

One of the recommended treatments for breast cancer is neoadjuvant chemotherapy (NCT), however, only 20% of the patients subject to this therapy present pathologic complete response (pCR). If exercise-induced tumour size reductions observed in preclinical studies translates to humans, physical training could emerge as a way of increasing rates of pCR to NCT, which would be a valuable clinical achievement. The present randomized controlled trial primary aim is to assess the impact of a physical exercise intervention the NCT efficacy. Following a parallel-arm design, 86 women with primary BC wil

Trial Details

NCT ID
NCT05976815
Phase
NA
Sponsor
University Institute of Maia
Status
RECRUITING
Cancer Type
Inflammatory Breast Cancer Breast Cancer
Interventions
  • Combined Aerobic and Resistance Exercise
Locations (sample)
  • Vila Nova de Gaia, Porto District, Portugal|41.12401,-8.61241

Key Eligibility Criteria

  • being female gender;
  • age equals or greater than 18 years old;
  • having a newly diagnosed histologically confirmed breast carcinoma IA-IIIC;
  • planned to receive neoadjuvant chemotherapy with anthracyclines or taxanes, that might be associated to anti-HER2 drugs;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Inflammatory Breast Cancer Breast Cancer Trials on Trialify →